Share Price | Modern Diagnostic & Research Centre Ltd Stock Analysis & Recommendation

Q: What does Modern Diagnost. do?

Overview: Modern Diagnostic & Research Centre Ltd operates in the healthcare services industry, focusing on diagnostic services, and is categorized as a micro-cap company.History: The company was incorporated as "Modern Diagnostic & Research Centre Private Limited" on April 16, 2012, after starting operations in 1985 under the name 'Modern X-Ray and Clinical Lab'. There are no recent sales and profit reports available.Financial Snapshot: Most recent Net Sales: N/A Most recent Net Profit: N/A Market-cap value: INR 85 Cr (Micro Cap)Key Metrics: P/E: 15.00 Industry P/E: 67 Dividend Yield: 0.00% Debt-Equity: 0.47 Return on Equity: 8.97% Price-to-Book: 1.46 Contact Details: Address: Not available Phone: Not available Email: Not available Website: Not available

Q: Who are the peers of the Modern Diagnost.?

Peers: The peers of Modern Diagnost. are Aspira Pathlab, Choksi Laborator, Royal Sense, Shree Pacetronix, Amkay Products, KMS Medisurgi, N G Industries, Aakaar Medical.Quality Snapshot: Excellent management risk is observed at Royal Sense, Shree Pacetronix, Amkay Products, N G Industries, and Aakaar Medical, while Average management risk is found at KMS Medisurgi. Below Average management risk is noted at Aspira Pathlab and Choksi Laborator. Growth is Excellent at Royal Sense, Good at Choksi Laborator, Shree Pacetronix, Amkay Products, and Aakaar Medical, while Below Average growth is seen at Aspira Pathlab, KMS Medisurgi, and N G Industries. Average capital structure is present at Aspira Pathlab, while Good capital structure is found at Royal Sense, Shree Pacetronix, Amkay Products, KMS Medisurgi, N G Industries, and Aakaar Medical.Return Snapshot: The peer with the highest 1-year return is Aspira Pathlab at 41.50%, while the lowest is Royal Sense at -62.36%. Modern Diagnost.'s 1-year return is not available for comparison. Additionally, KMS Medisurgi and N G Industries have negative six-month returns.

Q: How big is Modern Diagnost.?

As of 14th August, Market Cap: Modern Diagnostic & Research Centre Ltd has a market capitalization of 77.01 Cr, categorizing it as a Micro Cap company.Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 20.73 Cr and Total Assets valued at 64.57 Cr.

Technical Trend Update: Modern Diagnost. witnessed a change in Technical Grade on 01 Sep 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

35.2 k (-12.00%) Volume

Shareholding (Mar 2026)

FII

0.03%

Held by 1 FIIs

DII

15.49%

Held by 1 DIIs

Promoter

72.85%

Why is Modern Diagnostic & Research Centre Ltd falling/rising?

02-Sep-2026

As of 01-Sep, the stock price of Modern Diagnostic & Research Centre Ltd is at Rs 48.75, reflecting a 6.11% decline and a bearish trend, as it is significantly below its moving averages and close to its 52-week low. The stock has underperformed the sector and the benchmark Sensex, with a total drop of 14.1% over the last two days.

View full answer

Which are the latest news on Modern Diagnost.?

02-Sep-2026

No latest news for Modern Diagnost. found.

What does Modern Diagnost. do?

01-Sep-2026

Modern Diagnostic & Research Centre Ltd provides diagnostic services in the healthcare sector and is classified as a micro-cap company with a market cap of INR 85 Cr. It has a P/E ratio of 15.00 and a debt-equity ratio of 0.47, but lacks recent sales and profit reports.

View full answer

Who are the peers of the Modern Diagnost.?

01-Sep-2026

Peers of Modern Diagnost. include Aspira Pathlab, Choksi Laborator, Royal Sense, Shree Pacetronix, Amkay Products, KMS Medisurgi, N G Industries, and Aakaar Medical. Aspira Pathlab has the highest 1-year return at 41.50%, while Royal Sense has the lowest at -62.36%.

View full answer

How big is Modern Diagnost.?

14-Aug-2026

As of 14th August, Modern Diagnostic & Research Centre Ltd has a market capitalization of 77.01 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.

View full answer

When is the next results date for Modern Diagnostic & Research Centre Ltd?

22-May-2026

The next results date for Modern Diagnostic & Research Centre Ltd is 29 May 2026.

View full answer

Compare Modern Diagnost. with Similar Stocks

Invicta Diagnos.Royal Sense Aakaar Medical

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 73 Cr (Micro Cap)

P/E

14.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.47

Return on Equity

8.97%

Price to Book

1.26

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-14.89%

6 Months

-36.92%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Modern Diagnost. for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

26-Aug-2026 | Source : BSE

Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday 03rd day of September 2026 inter alia to consider and approve the appointment of Scrutinizer approval of Director Report & approval of AGM notice & other businesses

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Aug-2026 | Source : BSE

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for quarter ended June 30 2026

Financial Results For The Half Year And Year Ended 31.03.2026

29-May-2026 | Source : BSE

Financial results for the half year and year ended 31 March 2026

Corporate Actions

BOARD MEETING

03 Sep 2026

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

4.73

Debt to EBITDA (avg)

2.09

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.34

Tax Ratio

12.35%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

15.51%

ROCE (avg)

20.68%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.26

EV to EBIT

13.69

EV to EBITDA

8.05

EV to Capital Employed

1.17

EV to Sales

1.22

PEG Ratio

Dividend Yield

ROCE (Latest)

8.58%

ROE (Latest)

8.97%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

KST

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.03%)

Promoter with highest holding

Devendra Singh Yadav (61.2%)

Highest Public shareholder

Aarth Aif Growth Fund (4.48%)

Individual Investors Holdings

4.75%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Modern Diagnost."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.92",
          "val2": "39.98",
          "chgp": "-0.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.08",
          "val2": "9.67",
          "chgp": "-47.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.46",
          "val2": "0.95",
          "chgp": "53.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.08",
          "val2": "4.96",
          "chgp": "-58.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.73%",
          "val2": "24.19%",
          "chgp": "-11.46%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Modern Diagnost."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 6.62% vs 16.12% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -41.47% vs 54.92% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "83.11",
          "val2": "77.95",
          "chgp": "6.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.59",
          "val2": "17.97",
          "chgp": "-29.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.44",
          "val2": "1.91",
          "chgp": "27.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.25",
          "val2": "8.97",
          "chgp": "-41.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.15%",
          "val2": "23.05%",
          "chgp": "-7.90%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26

Mar'26

Sep'24

Change(%)

Net Sales

39.92

39.98

-0.15%

Operating Profit (PBDIT) excl Other Income

5.08

9.67

-47.47%

Interest

1.46

0.95

53.68%

Exceptional Items

0.00

Standalone Net Profit

2.08

4.96

-58.06%

Operating Profit Margin (Excl OI)

12.73%

24.19%

-11.46%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

83.11

77.95

6.62%

Operating Profit (PBDIT) excl Other Income

12.59

17.97

-29.94%

Interest

2.44

1.91

27.75%

Exceptional Items

0.00

Standalone Net Profit

5.25

8.97

-41.47%

Operating Profit Margin (Excl OI)

15.15%

23.05%

-7.90%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 6.62% vs 16.12% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -41.47% vs 54.92% in Mar 2025

All Annual Results

Company CV

About Modern Diagnostic & Research Centre Ltd

Modern Diagnostic & Research Centre Ltd

Micro Cap

Healthcare Services

The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992. Modern Diagnostic & Research Centre Limited was erstwhile incorporated as "Modern Diagnostic & Research Centre Private Limited" as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi .

Company Coordinates

No Company Details Available